Erytech Pharma SA ERYP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11/25/22 EST
0.60quote price arrow down-0.005 (-0.8264%)
Volume
1,230
52 week range
0.50 - 2.99
Loading...
  • Open0.561
  • Day High0.615
  • Day Low0.561
  • Prev Close0.605
  • 52 Week High2.99
  • 52 Week High Date11/30/21
  • 52 Week Low0.50
  • 52 Week Low Date09/28/22

Key Stats

  • Market Cap18.611M
  • Shares Out31.02M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta2.04
  • YTD % Change-73.83

KEY STATS

  • Open0.561
  • Day High0.615
  • Day Low0.561
  • Prev Close0.605
  • 52 Week High2.99
  • 52 Week High Date11/30/21
  • 52 Week Low0.50
  • 52 Week Low Date09/28/22
  • Market Cap18.611M
  • Shares Out31.02M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta2.04
  • YTD % Change-73.83

RATIOS/PROFITABILITY

  • EPS (TTM)-0.71
  • P/E (TTM)-0.84
  • Fwd P/E (NTM)-0.27
  • EBITDA (TTM)-25.427M
  • ROE (TTM)-91.39%
  • Revenue (TTM)28.161M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-98.73%
  • Debt To Equity (MRQ)76.94%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Erytech Pharma SA

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The Company's technology is based on the use of human red blood...
Jean-Paul Kress M.D.
Non-Executive Independent Chairman of the Board
Gil Beyen
Chief Executive Officer, Director
Eric Soyer
Chief Financial Officer, Chief Operating Officer, Deputy General Manager
Stewart Craig Ph.D.
Chief Technical Officer
Address
60 avenue Rockefeller, Batiment Adenine
Lyon
69008
France

Top Peers

SYMBOLLASTCHG%CHG
HGEN
Humanigen Inc
0.1438+0.0001+0.0696%
PULM
Pulmatrix Inc
3.66+0.05+1.39%
EFTR
eFFECTOR Therapeutics Inc
0.4702-0.0006-0.1274%
APVO
Aptevo Therapeutics Inc
2.91-0.06-2.02%
CBIO
Catalyst Biosciences Inc
0.55-0.005-0.9009%